Beyond glycaemic control: How far have we come?

Boehringer Ingelheim and Eli Lilly and Company |
Wednesday

Chair: Jiten Vora (UK) 

18:45 – 18:50Welcome and introductionJiten Vora (UK) 
18:50 – 19:10Discussion between two expertsJiten Vora (UK) 
Sarah Davies (UK)
19:10 – 19:15Audience Q&A, summary and closeAll faculty
moderated by Jiten Vora (UK)